Repository logo
 

User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Chen, Natalie S 
Boughton, Charlotte K  ORCID logo  https://orcid.org/0000-0003-3272-9544
Hartnell, Sara 
Fuchs, Julia 
Allen, Janet M 

Abstract

CamAPS FX (CamDiab, Cambridge, UK) is a hybrid closed-loop app hosting the Cambridge closed-loop algorithm on an Android smartphone, and is approved in the EU for use in children ≥1 year, and adults (including during pregnancy) with type 1 diabetes (T1D). The interoperable CamAPS FX app receives glucose data from a compatible CGM system (Dexcom G6; Dexcom, San Diego, CA), connects to a compatible insulin pump (Dana Diabecare RS and DANA-i; Sooil, Seoul, South Korea) to direct glucose-responsive insulin delivery every 8-12 minutes, includes a bolus calculator allowing discrete bolusing via the app, and streams data in real-time to cloud-based diabetes data repositories (Diasend/Glooko, Gothenburg, Sweden).

Description

Keywords

Diabetes Mellitus, Type 1, Humans, Insulin Infusion Systems, Mobile Applications

Journal Title

Diabetes Care

Conference Name

Journal ISSN

0149-5992
1935-5548

Volume Title

Publisher

American Diabetes Association

Rights

All rights reserved
Sponsorship
Wellcome Trust (100574/Z/12/Z)
Medical Research Council (MC_UU_12012/5)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Wellcome Trust (100574/B/12/Z)
Department of Health (via National Institute for Health Research (NIHR)) (EME 14/23/09)
National Institute of Diabetes and Digestive and Kidney Diseases (DP3DK112176)
European Commission Horizon 2020 (H2020) Societal Challenges (731560)
National Institute for Health Research (NIHR) (via University of East Anglia (UEA)) (16/35/01 / R203882)
National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK108520)
Helmsley Charitable Trust (#2016PG-T1D045)
Helmsley Charitable Trust (#2016PG-T1D046)
NIHR Evaluation Trials and Studies Coordinating Centre (14/23/09)
Medical Research Council (MC_PC_12012)